ResMed Inc. director Ronald R. Taylor filed a Form 4 with the SEC on November 20, 2026, disclosing his beneficial ownership of ResMed common stock following his departure from the company's board of directors on November 18, 2026.
Key Highlights
- Board departure: Ronald R. Taylor ceased to serve as a director at the conclusion of ResMed's 2026 annual meeting of stockholders, held on November 18, 2026.
- Beneficial ownership reported: Following the reported transaction, Taylor held 24,771 shares of ResMed Common Stock with direct ownership form indicated.
- No transaction recorded: Table I lists no transaction code, amount acquired or disposed of, or price, reflecting only a holdings disclosure at the time of the event.
- No derivative securities: Table II contains no derivative security transactions or holdings for Taylor.
- Issuer: ResMed Inc., traded on NYSE:RMD.
Taylor's Departure From ResMed's Board and Final Ownership Disclosure
According to the filing, Ronald R. Taylor submitted this Form 4 in connection with his departure from the ResMed Inc. board of directors. The filing states that Taylor "ceased to serve as a director at the conclusion of the 2026 annual meeting of stockholders held on November 18, 2026." The form was signed by Taylor and dated November 20, 2026.
Table I of the filing reports that Taylor beneficially owned 24,771 shares of ResMed Common Stock following the reported transaction, held in direct form. No transaction code, acquisition, disposition, or price is recorded in the table, indicating the entry reflects a post-event holdings disclosure rather than a purchase or sale. The filing does not indicate whether a Rule 10b5-1 plan was in effect, as the relevant checkbox on the form is not checked.
Table II, covering derivative securities such as options or warrants, is blank, indicating Taylor held no such instruments. The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934, which governs ownership reporting by officers, directors, and certain shareholders.
What Was Disclosed
Ronald R. Taylor filed a Form 4 disclosing his beneficial ownership of 24,771 shares of ResMed Common Stock (NYSE:RMD) following his resignation from the board at the November 18, 2026 annual stockholder meeting. No securities were acquired or disposed of in the reported period.




Please wait processing your request...